Cancer-related Fatigue Clinical Trial
Official title:
The Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer: A Double Blind Randomized Trial
White light therapy is one of the non-pharmacological methods in the management of fatigue. Cancer-related fatigue (CRF) is a persistent, subjective sense of physical, emotional, and/or cognitive tiredness or burnout. It is associated with cancer or cancer treatment from the first diagnosis until the end of life that is not proportional to recent physical activity. It was founded that 10,000 Lux bright white light administered in the morning hours reduced fatigue by 17% in patients with cancer and that the mean fatigue scores of patients decreased from 30.37 to 9.48 compared to before the light administration. According to NCCN (2020), white light of 10,000 Lux can be applied for 30-90 minutes in the morning hours to regulate sleep and manage fatigue in the post treatment period as well as in cancer patients receiving active treatment. However, studies on this subject consist of small sample groups, and more studies are needed to identify the risks and benefits of the application and to determine the optimal application time and duration. The present study was aimed to evaluate the effect of white light on the fatigue levels of patients with gynecological cancer who were treated with chemotherapy. The patients with high levels of fatigue in every dimension were selected so as to have a homogeneous group. The research hypotheses were determined as follows: H0: White light has no effect on fatigue levels in patients with gynecological cancer. H1: White light reduces fatigue levels in patients with gynecological cancer.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05428527 -
Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue
|
||
Completed |
NCT04563013 -
Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients
|
N/A | |
Recruiting |
NCT05613465 -
Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo
|
N/A | |
Recruiting |
NCT05448573 -
A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening
|
||
Completed |
NCT03897556 -
Effect of High-Dose Guarana And Cancer-Related Fatigue
|
N/A | |
Recruiting |
NCT04147312 -
Fufang E'Jiao Jiang Intervening Cancer-related Fatigue
|
N/A | |
Active, not recruiting |
NCT03318224 -
Fatigue Prevalence, Severity, and State of Treatment in Germany
|
||
Completed |
NCT01720550 -
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
|
Phase 4 | |
Not yet recruiting |
NCT06381557 -
Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules
|
Phase 4 | |
Completed |
NCT03049384 -
Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors
|
N/A | |
Withdrawn |
NCT03211273 -
Longitudinal Investigation of Cancer-related Fatigue
|
||
Recruiting |
NCT02661308 -
Reducing Cancer Side-effects With Systematic Light Exposure
|
N/A | |
Completed |
NCT02740959 -
Effects of PG2 on Fatigue-Related Symptom Clusters
|
N/A | |
Completed |
NCT03314805 -
PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy
|
Phase 2 | |
Completed |
NCT03553355 -
Effects of Infrared Laser Moxibustion on Cancer-related Fatigue in Breast Cancer Patients
|
N/A | |
Recruiting |
NCT05440227 -
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
|
Phase 2 | |
Enrolling by invitation |
NCT01228773 -
The Efficacy of Health Navigation® for Cancer-Related Fatigue in Cancer Survivors
|
Phase 2 | |
Not yet recruiting |
NCT04947969 -
Clinical Effect of Laser Acupuncture on Improving Cancer-related Fatigue
|
N/A | |
Not yet recruiting |
NCT00552552 -
Development and Evaluation of a Cancer-Related Fatigue Patient Education Program
|
N/A | |
Active, not recruiting |
NCT05390398 -
Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention
|
N/A |